Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0W5NB
|
|||
| Former ID |
DNC002825
|
|||
| Drug Name |
1h-Benoximidazole-2-Carboxylic Acid
|
|||
| Synonyms |
1H-Benzimidazole-2-carboxylic acid; 2849-93-6; 2-Benzimidazolecarboxylic acid; 1H-benzo[d]imidazole-2-carboxylic acid; Benzimidazole-2-carboxylic acid; 1H-Benzoimidazole-2-carboxylic acid; 1H-1,3-benzodiazole-2-carboxylic acid; Benzoimidazole-2-carboxylic acid; benzimidazole-2-yl-carboxylic acid; 1H-BENOXIMIDAZOLE-2-CARBOXYLIC ACID; 1h-1,3-benzimidazole-2-carboxylic acid; RHXSYTACTOMVLJ-UHFFFAOYSA-N; PubChem8062; AC1L5PLZ; benzimidazolecarboxylic acid; AC1Q1HJ4; benzimidazole carboxylic acid; 2-Carboxy-1H-benzimidazole
Click to Show/Hide
|
|||
| Drug Type |
Small molecular drug
|
|||
| Indication | Discovery agent [ICD-11: N.A.] | Investigative | [1] | |
| Structure |
 |
Download2D MOL |
||
| Formula |
C8H6N2O2
|
|||
| Canonical SMILES |
C1=CC=C2C(=C1)NC(=N2)C(=O)O
|
|||
| InChI |
1S/C8H6N2O2/c11-8(12)7-9-5-3-1-2-4-6(5)10-7/h1-4H,(H,9,10)(H,11,12)
|
|||
| InChIKey |
RHXSYTACTOMVLJ-UHFFFAOYSA-N
|
|||
| CAS Number |
CAS 2849-93-6
|
|||
| PubChem Compound ID | ||||
| PubChem Substance ID |
90412, 112541, 3212605, 7597786, 7890876, 9385018, 10591150, 15437560, 26697086, 29203526, 30032720, 46508154, 48334915, 48334916, 57400210, 57706123, 79311729, 87620175, 90341909, 93578912, 99216063, 103100168, 104452676, 108221446, 117357391, 117608883, 117608884, 117664607, 118049449, 118278461, 124766653, 125000496, 125346972, 126576947, 126606582, 126614481, 126625956, 126648963, 127347253, 129131897, 134963933, 136070265, 136371108, 136908554, 136987481, 136995762, 137029747, 137293894, 143357007, 143407301
|
|||
| ChEBI ID |
CHEBI:46117
|
|||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Cathepsin D (CTSD) | Target Info | Inhibitor | [1] |
| BioCyc | Thyroid hormone biosynthesis | |||
| KEGG Pathway | Sphingolipid signaling pathway | |||
| Lysosome | ||||
| Tuberculosis | ||||
| NetPath Pathway | IL2 Signaling Pathway | |||
| Pathway Interaction Database | LKB1 signaling events | |||
| Ceramide signaling pathway | ||||
| Direct p53 effectors | ||||
| Validated nuclear estrogen receptor alpha network | ||||
| Reactome | Collagen degradation | |||
| Metabolism of Angiotensinogen to Angiotensins | ||||
| MHC class II antigen presentation | ||||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | How many drug targets are there Nat Rev Drug Discov. 2006 Dec;5(12):993-6. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.